Torre Lazur wins AOR for Entereg

Share this article:
Torre Lazur McCann Healthcare Group was named AOR for Entereg—the first and only FDA-approved agent indicated to accelerate the time to upper and lower GI recovery following partial large or small bowel resection surgery with primary anastomosis—and will re-launch the brand for GlaxoSmithKline and Adolor.

Meanwhile, its sister agency, Torre Lazur McCann London, won the global launch for a new contraceptive by Bayer Schering Pharma, plus the re-launch across Europe of Invega for schizophrenia, an atypical antipsychotic that helps treat both the “positive” and the “negative” symptoms of schizophrenia.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.